Combined treatment options for resectable common bile duct cancer patients-Reference-Cited by-同舟云学术

Combined treatment options for resectable common bile duct cancer patients

Published:2020-09-20 Issue:3 Volume:25 Page:123-130
ISSN:2408-9524
Container-title:Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery
language:
Short-container-title:Ann. hir. gepatol.

Author:

Polyakov A. N.¹^ORCID,Podluzhny D. V.¹^ORCID,Patyutko Y. I.¹^ORCID,Chulkova S. V.²^ORCID,Egorova A. V.³^ORCID,Bazin I. S.¹^ORCID,Shorikov M. A.¹^ORCID,Frantsev D. Yu.¹^ORCID,Syskova A. Yu.³^ORCID

Affiliation:

1. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

2. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Pirogov Russian National Research Medical University

3. Pirogov Russian National Research Medical University

Publisher

Annals of Surgical Hepatology

Subject

Gastroenterology,Hepatology,Surgery

Reference20 articles.

1. Courtin-Tanguy L., Turrini O., Bergeat D., Truant S., Darnis B., Delpero J., Mabrut J., Regenet N., Sulpice L. Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarci-noma. HPB. 2018; 20 (5): 405-410. https://doi.org/10.1016/j.hpb.2017.10.016.

2. Kim B., Kim K., Chie E., Kwon J., Jang J., Kim S., Oh D., Bang Y. Long-term outcome of distal cholangiocarcinoma after pancreaticoduodenectomy followed by adjuvant chemoradiotherapy: a 15-year experience in a single institution. Cancer Res. Treat. 2017; 49 (2): 473-483. https://doi.org/10.4143/crt.2016.166.

3. Kim Y., Hwang I., Park S., Go S., Kang J., Park I., Oh S., Ji J., Song H., Park S., Kim S., Park J. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemother. Pharmacol. 2016; 77 (5): 979-985. https://doi.org/10.1007/s00280-016-3014-x.

4. Bergeat D., Turrini O., Courtin-Tanguy L., Truant S., Darnis B., Delpero J., Mabrut J., Regenet N., Sulpice L. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort. Langenbeck's Arch. Surg. 2018; 403 (6): 701-709. https://doi.org/10.1007/s00423-018-1702-1.

5. Ecker B., Vining C., Roses R., Maggino L., Lee M., Drebin J., Fraker D., Vollmer C., Datta J. Identification of patients for adjuvant therapy after resection of carcinoma of the extrahepatic bile ducts: a propensity score-matched analysis. Ann. Surg. Oncol. 2018; 24 (13): 3926-3933. https://doi.org/10.1245/s10434-017-6095-9.